DE3369143D1 - Highly purified human antihemophilic factor and method for the preparation thereof - Google Patents
Highly purified human antihemophilic factor and method for the preparation thereofInfo
- Publication number
- DE3369143D1 DE3369143D1 DE8383107420T DE3369143T DE3369143D1 DE 3369143 D1 DE3369143 D1 DE 3369143D1 DE 8383107420 T DE8383107420 T DE 8383107420T DE 3369143 T DE3369143 T DE 3369143T DE 3369143 D1 DE3369143 D1 DE 3369143D1
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- highly purified
- purified human
- antihemophilic factor
- human antihemophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960002661 human antihemophilic factor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/405,456 US4495175A (en) | 1982-08-05 | 1982-08-05 | Preparation of highly purified human antihemophilic factor |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3369143D1 true DE3369143D1 (en) | 1987-02-19 |
Family
ID=23603775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8383107420T Expired DE3369143D1 (en) | 1982-08-05 | 1983-07-28 | Highly purified human antihemophilic factor and method for the preparation thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US4495175A (de) |
EP (1) | EP0104356B1 (de) |
JP (1) | JPS5944322A (de) |
AU (1) | AU567683B2 (de) |
CA (1) | CA1213214A (de) |
DE (1) | DE3369143D1 (de) |
ES (1) | ES8501979A1 (de) |
MX (1) | MX7309E (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4614795A (en) * | 1982-08-05 | 1986-09-30 | University Of Rochester | Deglycosylated Human Factor VIII:C |
EP0148843B2 (de) * | 1983-03-21 | 1994-05-04 | Novo Nordisk A/S | Antihämophilie-faktor-viii-konzentrat und dessen herstellungsverfahren |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US5043428A (en) * | 1984-08-31 | 1991-08-27 | Behringwerke Aktiengesellschaft | Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production |
US4543210A (en) * | 1984-10-04 | 1985-09-24 | Miles Laboratories, Inc. | Process for producing a high purity antihemophilic factor concentrate |
SE8501050D0 (sv) * | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
GB8505882D0 (en) * | 1985-03-07 | 1985-04-11 | Central Blood Lab Authority | Purification of blood coagulation factor viii |
JPS61280866A (ja) * | 1985-06-07 | 1986-12-11 | アルフア・セラピユ−テイツク・コ−ポレイシヨン | 人血液凝固第8因子の分離方法 |
AT391808B (de) * | 1986-11-03 | 1990-12-10 | Immuno Ag | Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion |
US5177191A (en) * | 1987-12-21 | 1993-01-05 | Miles, Inc. | Gel filtration of factor VIII |
EP0321835B1 (de) * | 1987-12-21 | 1994-09-28 | Miles Inc. | Faktor VIII- Gelfiltration |
WO1989009784A1 (en) * | 1988-04-08 | 1989-10-19 | Commonwealth Serum Laboratories Commission | Production of heat-stable factor viii concentrate |
EP0367840B1 (de) | 1988-11-05 | 1993-02-03 | Octapharma AG | Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie |
FR2644064B1 (fr) * | 1989-02-17 | 1994-05-27 | Aquitaine Dev Transf Sanguine | Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant |
DE3926034C3 (de) * | 1989-08-07 | 1996-11-21 | Behringwerke Ag | Verfahren zur Herstellung eines stabilen Faktors VIII |
FR2651437A1 (fr) * | 1989-09-05 | 1991-03-08 | Lille Transfusion Sanguine | Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total. |
DK162233C (da) * | 1989-11-09 | 1992-03-16 | Novo Nordisk As | Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii |
IT1248723B (it) * | 1990-06-12 | 1995-01-26 | Scalvo S P A | Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo |
FR2681867B1 (fr) * | 1991-09-26 | 1993-12-31 | Pasteur Merieux Serums Vaccins | Procede de purification du facteur viii et preparations obtenues. |
US5516509A (en) * | 1993-03-31 | 1996-05-14 | International Beauty Design, Inc. | Quick-drying nail coating for use over nail polish |
US5407666A (en) * | 1993-04-05 | 1995-04-18 | International Beauty Design, Inc. | Removable, hard, durable, nail coating |
SE504074C2 (sv) * | 1993-07-05 | 1996-11-04 | Pharmacia Ab | Proteinberedning för subkutan, intramuskulär eller intradermal administrering |
US7244824B2 (en) * | 1995-01-19 | 2007-07-17 | Quadrant Drug Delivery Limited | Dried blood factor composition comprising trehalose |
GB9501040D0 (en) * | 1995-01-19 | 1995-03-08 | Quadrant Holdings Cambridge | Dried composition |
US7253262B2 (en) * | 1995-01-19 | 2007-08-07 | Quandrant Drug Delivery Limited | Dried blood factor composition comprising trehalose |
US5659017A (en) * | 1995-11-07 | 1997-08-19 | Alpha Therapeutic Corporation | Anion exchange process for the purification of Factor VIII |
US6077940A (en) * | 1997-12-24 | 2000-06-20 | Genentech, Inc. | Free solution ligand interaction molecular separation method |
US6391609B1 (en) | 1998-10-07 | 2002-05-21 | Sigma-Aldrich Co. | Thromboplastin reagents and methods for preparing and using such reagents |
BR0008405B1 (pt) | 1999-02-22 | 2014-04-22 | Baxter Int | Composição de fator viii formulada sem a adição de albumina, uso de uma composição de fator viii, e, método de liofilizar uma formulação farmacêutica aquosa |
US20100168018A1 (en) * | 2008-11-07 | 2010-07-01 | Baxter International Inc. | Factor viii formulations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188318A (en) * | 1975-06-16 | 1980-02-12 | Edward Shanbrom | Simplified method for preparation of high yield, high purity Factor VIII concentrate |
US4278594A (en) * | 1979-06-19 | 1981-07-14 | David Amrani | Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma |
US4364861A (en) * | 1980-05-27 | 1982-12-21 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
CA1178887A (en) * | 1981-10-01 | 1984-12-04 | Gail A. Rock | Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique |
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
US4397841A (en) * | 1982-06-28 | 1983-08-09 | Monsanto Company | Production of blood coagulation factor VIII:C |
AU555305B2 (en) * | 1982-09-29 | 1986-09-18 | Bayer Corporation | Antihemophilic factor concentrate |
-
1982
- 1982-08-05 US US06/405,456 patent/US4495175A/en not_active Expired - Lifetime
-
1983
- 1983-07-28 EP EP83107420A patent/EP0104356B1/de not_active Expired
- 1983-07-28 DE DE8383107420T patent/DE3369143D1/de not_active Expired
- 1983-07-29 CA CA000433578A patent/CA1213214A/en not_active Expired
- 1983-08-01 AU AU17472/83A patent/AU567683B2/en not_active Ceased
- 1983-08-03 JP JP58141256A patent/JPS5944322A/ja active Pending
- 1983-08-04 MX MX8310732U patent/MX7309E/es unknown
- 1983-08-05 ES ES524768A patent/ES8501979A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU1747283A (en) | 1984-02-09 |
CA1213214A (en) | 1986-10-28 |
EP0104356A1 (de) | 1984-04-04 |
AU567683B2 (en) | 1987-12-03 |
ES524768A0 (es) | 1984-12-16 |
EP0104356B1 (de) | 1987-01-14 |
MX7309E (es) | 1988-05-10 |
JPS5944322A (ja) | 1984-03-12 |
US4495175A (en) | 1985-01-22 |
ES8501979A1 (es) | 1984-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3369143D1 (en) | Highly purified human antihemophilic factor and method for the preparation thereof | |
GB8307723D0 (en) | Wheelchair | |
GB8415967D0 (en) | Wheelchair | |
DE3368502D1 (en) | Chair | |
EP0088956A3 (en) | Dental chair | |
DE3368196D1 (en) | Dental chair | |
GB8400003D0 (en) | Wheelchair | |
IE830028L (en) | Adjustable staff | |
GB2132954B (en) | Wheelchairs | |
GB2136742B (en) | Wheelchairs | |
DE3370796D1 (en) | Alpha-iminodiacetonitriles and methods for their preparation | |
GB8321023D0 (en) | Wheelchair | |
DE3374560D1 (en) | Cyanoalkylpiperazines and methods for their preparation and use | |
DE3366832D1 (en) | Dental chair | |
GB8620252D0 (en) | First-aid canister | |
DE3379030D1 (en) | Antihemophilic factor concentrate and process for its preparation | |
CA49742S (en) | Treatment chair | |
IE820926L (en) | Wheelchair | |
CA50499S (en) | Chair | |
CA50147S (en) | Chair | |
CA49224S (en) | Chair | |
CA50668S (en) | Chair | |
CA49335S (en) | Chair handbell | |
CA50031S (en) | Chair | |
CA50702S (en) | Chair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |